$47.370
-1.781 (-3.76%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de GPCR por análisis de gráficos similares
Alphio's GPCR stock price prediction model matches the current Structure Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $47.58 (+0.44%). The 1-week path is $49.18 (+3.82%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Structure Therapeutics Inc?
Structure Therapeutics Inc (GPCR) is currently priced at $47.37, which is significantly lower than the analyst price target of $111 from Canaccord. However, the stock has a low RSI of 22.854, indicating it is oversold, but it also has a negative forward P/E ratio of 0, suggesting uncertainty about future earnings. The main risk is the declining net income, with a loss of $106,159,000 reported in Q2 2026, which raises concerns about the company's financial health.
GPCR cerró en $47.37 el Friday, tras bajar -3.76%
Structure Therapeutics Inc (GPCR) last closed at $47.37, losing -3.76%. These facts feed the 1-day and 1-week GPCR price prediction above.
Factores de la previsión
Los factores de la previsión de Structure Therapeutics Inc (GPCR) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de GPCR, ordenadas por similitud.
Análisis de estacionalidad de GPCR
Historically the probability of a positive August return for GPCR is 3.17%. January offers the highest probability of a positive month at 65.57%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de GPCR
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $18.66 | $21.18 | $22.34 | -55.29% |
| Sep 2026 | $15.83 | $17.77 | $18.37 | -62.50% |
| Oct 2026 | $16.92 | $17.66 | $20.06 | -62.73% |
| Nov 2026 | $20.72 | $23.24 | $23.49 | -50.93% |
| Dec 2026 | $20.36 | $22.10 | $24.61 | -53.34% |
En 2026, se proyecta que Structure Therapeutics Inc (GPCR) oscile entre $15.83 y $24.61.
Previsión mensual de Structure Therapeutics Inc para 2026
En Aug de 2026, se proyecta que Structure Therapeutics Inc promedie $21.18, con un mínimo de $18.66 y un máximo de $22.34.
En Sep de 2026, se proyecta que Structure Therapeutics Inc promedie $17.77, con un mínimo de $15.83 y un máximo de $18.37.
En Oct de 2026, se proyecta que Structure Therapeutics Inc promedie $17.66, con un mínimo de $16.92 y un máximo de $20.06.
En Nov de 2026, se proyecta que Structure Therapeutics Inc promedie $23.24, con un mínimo de $20.72 y un máximo de $23.49.
En Dec de 2026, se proyecta que Structure Therapeutics Inc promedie $22.10, con un mínimo de $20.36 y un máximo de $24.61.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.